triple combination nitazoxanide , ribavirin , and hydroxychloroquine results in the multiplicative reduction of in vitro sars-cov-2 viral replication.
triple combination nitazoxanide , ribavirin , and hydroxychloroquine results in the multiplicative reduction of in vitro sars-cov-2 viral replication.
conclusionsa triple combination of tizoxanide, ribavirin, and hydroxychloroquine produced a reduction in sars-cov-2 viral replication in vero e6 cells, warranting exploration in additional cell lines as well as human clinical trials.", "conclusions a triple combination of tizoxanide, ribavirin, and hydroxychloroquine produced a reduction in sars-cov-2 viral replication in vero e6 cells, warranting exploration in additional cell lines as well as human clinical trials.")